| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 62.41B | 53.29B | 44.51B | 20.04B | 20.02B |
| Gross Profit | 50.29B | 43.30B | 36.39B | 15.53B | 15.43B |
| EBITDA | 16.61B | 14.99B | 12.14B | 960.00M | -393.00M |
| Net Income | 33.29B | 17.07B | 9.92B | 1.40B | -550.00M |
Balance Sheet | |||||
| Total Assets | 267.50B | 242.58B | 219.14B | 191.69B | 191.86B |
| Cash, Cash Equivalents and Short-Term Investments | 78.49B | 76.91B | 59.34B | 42.55B | 49.38B |
| Total Debt | 31.95B | 40.32B | 45.57B | 46.66B | 51.72B |
| Total Liabilities | 94.83B | 99.10B | 96.13B | 78.67B | 81.40B |
| Stockholders Equity | 171.02B | 142.55B | 122.18B | 112.28B | 109.68B |
Cash Flow | |||||
| Free Cash Flow | 13.58B | 19.03B | 21.40B | 2.14B | 1.90B |
| Operating Cash Flow | 14.38B | 19.63B | 22.00B | 2.64B | 2.48B |
| Investing Cash Flow | -4.18B | -6.05B | 5.92B | 1.14B | -4.15B |
| Financing Cash Flow | -14.66B | -6.71B | -2.55B | -6.72B | 3.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$242.21B | 10.44 | 21.02% | 0.41% | 17.19% | 94.71% | |
70 Outperform | HK$35.06B | 12.02 | 11.12% | 0.79% | 14.21% | 10.38% | |
66 Neutral | HK$102.99M | -45.00 | 0.78% | 4.55% | 32.99% | -94.85% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$232.83M | 3.23 | 5.15% | ― | 16.98% | -30.25% | |
56 Neutral | HK$89.00M | 12.94 | 16.42% | ― | 48.36% | -16.82% | |
55 Neutral | HK$398.00M | 9.73 | 12.44% | ― | -1.97% | -57.63% |